Calcium antagonist, lacidipine slows down progression of asymptomatic carotid atherosclerosis - Principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial

Bond, G. et al. (2002) Calcium antagonist, lacidipine slows down progression of asymptomatic carotid atherosclerosis - Principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Circulation, 106, pp. 2422-2427. (doi: 10.1161/01.CIR.0000039288.86470.DD)

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Reid, Professor John
Authors: Bond, G., Dal, P., Eckes, L., Hansson, L., Hennig, M., Magnani, B., Mancia, G., Neiss, A., Rahn, K., Reid, J., Rizzini, P., Rodicio, J., Safar, M., and Zanchetti, A.
College/School:College of Medical Veterinary and Life Sciences
Journal Name:Circulation

University Staff: Request a correction | Enlighten Editors: Update this record